O95271 (TNKS1_HUMAN) Homo sapiens (Human)

Poly [ADP-ribose] polymerase tankyrase-1 UniProtKBInterProSTRINGInteractive Modelling

1327 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

42 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
ARCs 1-3 of human Tankyrase-1 bound to a peptide derived from IRAP
5jhq
 Heteromer
Q9UIQ6; 		181-642
Assess
Complex structure of human poly-ADP-ribosyltransferase TNKS1 ARC2-ARC3 and P antigen family member …
6urq
 Heteromer
O60829; 		333-641
1×SO4;
Assess
Structural basis for the binding between Tankyrase-1 and USP25
5gp7
 Heteromer
Q9UHP3; 		799-957
2×GOL;
Assess
Crystal Structure of the wild-type SAM domain of human Tankyrase-1
5kni
homo-7-mer1026-1090
Assess
Crystal structure of the human Tankyrase 1 (TNKS) SAM domain (D1055R), crystal form 1
5ju5
homo-6-mer1025-1090
Assess
TANKYRASE-1 complexed with NVP-XAV939
3uh4
monomer1105-1316
1×ZN; 1×XAV; 4×SO4; 1×GOL;
Assess
Tankyrase 1 with Phthalazinone 1
5ece
monomer1105-1316
1×EDO; 1×5N2; 1×ZN;
Assess
Crystal structure of Tankyrase 1 with IWR2
4dvi
monomer1104-1314
1×ZN; 1×2IW;
Assess
Co-crystal structure of tankyrase 1 with compound 2 (5-(2-aminoquinazolin-6-yl)-N-(4,4-dimethyl-2-o…
4n3r
monomer1104-1314
1×ZN; 1×2GU;
Assess
Tankyrase-1 in complex with small molecule inhibitor
3udd
monomer1105-1315
1×ZN; 1×34M; 4×SO4; 3×GOL;
Assess
Co-crystal structure of tankyrase 1 with compound 4 [(4S)-3-{trans-4-[6-amino-5-(pyrimidin-2-yl)pyr…
4n4v
monomer1104-1314
1×ZN; 1×2GY;
Assess
TANKYRASE-1 complexed with small molecule inhibitor 4-chloro-5-cyano-N-{2-[4-(4-fluorobenzoyl)piper…
4li7
monomer1105-1315
3×SO4; 1×NA; 1×1XP;
Assess
Crystal structure of human tankyrase 1- catalytic PARP domain
2rf5
monomer1104-1314
1×ZN; 1×GOL;
Assess
Co-crystal structure of tankyrase 1 with compound 34
4msk
monomer1104-1314
1×ZN; 1×2C8;
Assess
Co-crystal structure of tnks1 with compound 52 [N~2-(5-chloro-2-methoxyphenyl)-N-[trans-4-(2-oxo-2,…
4k4e
monomer1104-1314
1×ZN; 1×K4E;
Assess
Crystal structure of tankyrase 1 with compound 4
4i9i
monomer1104-1314
1×ZN; 1×1DY;
Assess
Co-crystal structure of TNKS1 with compound 18 [4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-…
4k4f
monomer1104-1314
1×ZN; 1×K4F;
Assess
Structure of the catalytic domain of tankyrase 1 in complex with niraparib
7kkp
monomer1105-1314
1×ZN; 1×3JD; 3×SO4;
Assess
Human TNKS1 in complex with 3-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2H-pyrrolo[1,2-a]pyraz…
7ocv
monomer1105-1314
1×ACT; 1×V8B; 1×ZN;
Assess
Structure of the catalytic domain of tankyrase 1 in complex with olaparib
7kko
monomer1105-1314
1×ZN; 1×09L;
Assess
Structure of the catalytic domain of tankyrase 1
7kkm
monomer1105-1314
1×ZN;
Assess
The Crystal Structure of PARP5A from Biortus.
8x5j
monomer1104-1313
1×ZN; 1×TLA; 3×EDO;
Assess
Crystal structure of tankyrase 1 with compound 22
4msg
monomer1105-1314
1×ZN; 1×2C6;
Assess
Co-crystal structure of tankyrase 1 with compound 49
4mt9
monomer1105-1314
1×ZN; 1×2D6;
Assess
TANKYRASE-1 Complexed with small molecule inhibitor N-[(4-oxo-3,4-dihydroquinazolin-2-yl)methyl]-3-…
4li6
monomer1105-1314
1×ZN; 4×SO4; 1×1XO;
Assess
Tankyrase-1 complexed with small molecule inhibitor
4krs
monomer1105-1314
1×ZN; 4×SO4; 1×1SX;
Assess
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor
4u6a
monomer1105-1314
1×ZN; 1×3DN; 5×GOL; 2×EDO;
Assess
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor
4uuh
monomer1105-1314
1×ZN; 4×GOL; 4×EDO; 1×T40;
Assess
Tankyrase in complex with compound
4w5s
monomer1105-1314
1×GOL; 1×3J1; 1×ZN;
Assess
Crystal Structure of human Tankyrase-1 bound to K-756
5ety
monomer1105-1314
1×ZN; 1×K56;
Assess
Human TNKS1 in complex with 6,8-Difluoro-2-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-3H-quinazolin-4-one
6qxu
monomer1105-1313
1×BME; 1×JKN; 1×ZN;
Assess
Structure of the catalytic domain of tankyrase 1 in complex with talazoparib
7kkn
monomer1105-1313
1×ZN; 1×2YQ; 1×MES;
Assess
Crystal structure of Tankyrase 1 with IWR-8
4tor
monomer1105-1313
1×ZN; 1×IW8; 5×CL;
Assess
Structure of the catalytic domain of tankyrase 1 in complex with veliparib
7kkq
monomer1105-1313
1×78P; 1×ZN;
Assess
Crystal structure of Tankyrase 1 with 355
4tos
monomer1105-1313
1×ZN; 1×355;
Assess
Human Tankyrase 1 with small molecule inhibitor
4w6e
monomer1106-1314
1×ZN; 1×3J5;
Assess
Tankyrase-1 in complexed with PJ34
3uh2
monomer1105-1313
1×ZN; 2×P34; 4×SO4;
Assess
Tankyrase 1 with Phthalazinone 2
5ebt
monomer1106-1314
1×BU3; 1×5N8; 1×ZN;
Assess
Crystal structure of Tankyrase1 in complex with IWR1
4oa7
monomer1105-1313
1×ZN; 1×2XS;
Assess
TANKYRASE-1 complexed with small molecule inhibitor 2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo…
4li8
monomer1105-1313
1×ZN; 1×1XQ; 3×SO4;
Assess
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor
4uw1
monomer1105-1313
1×ZN; 1×GOL; 1×EDO; 1×92R;
Assess
Crystal structure of the human Tankyrase 1 (TNKS) SAM domain (D1055R), crystal form 2
5jti
monomer1027-1089
Assess

13 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5jhq.1.Amonomer0.86181-642
100.00
Assess
3utm.1.Bmonomer0.84335-641
99.14
Assess
8aly.1.Amonomer0.751028-1311
1×ZN;83.96
Assess
5jhq.1.Amonomer0.71493-955
43.24
Assess
5le2.1.Amonomer0.71184-642
39.51
Assess
5le2.2.Amonomer0.71338-797
40.84
Assess
5lec.1.Amonomer0.69490-943
39.60
Assess
1n11.1.Amonomer0.64218-646
35.23
Assess
5jhq.1.Amonomer0.58368-952
42.86
Assess
5le2.2.Amonomer0.57409-891
41.40
Assess
7ykr.1.Amonomer0.55338-789
27.60
Assess
5lec.1.Amonomer0.54182-893
38.98
Assess
5le2.1.Amonomer0.53182-893
38.70
Assess

6 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25jhq.1.Amonomer0.87181-641
99.79
Assess
Isoform 23utm.1.Amonomer0.87323-640
99.39
Assess
Isoform 25lec.1.Amonomer0.74184-641
36.87
Assess
Isoform 25le2.2.Amonomer0.73183-641
36.34
Assess
Isoform 25le3.3.Amonomer0.68183-489
39.06
Assess
Isoform 28wqd.1.Amonomer0.51181-639
23.11
Assess